Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
70.29B | 68.01B | 64.82B | 69.07B | 67.44B | 67.81B | Gross Profit |
15.05B | 15.41B | 14.09B | 15.05B | 14.73B | 13.97B | EBIT |
3.65B | 4.32B | 3.98B | 5.18B | 4.58B | 4.26B | EBITDA |
6.14B | 10.88B | 6.98B | 8.75B | 7.81B | 6.96B | Net Income Common Stockholders |
2.55B | 5.38B | 2.59B | 3.67B | 3.13B | 2.87B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
23.11B | 25.28B | 18.36B | 18.62B | 17.26B | 15.04B | Total Assets |
62.86B | 64.44B | 61.62B | 59.79B | 61.61B | 57.21B | Total Debt |
3.88B | 4.75B | 5.93B | 8.11B | 10.34B | 9.67B | Net Debt |
-19.23B | -20.52B | -10.71B | -8.75B | -5.03B | -3.53B | Total Liabilities |
22.23B | 24.67B | 24.26B | 26.36B | 30.19B | 29.34B | Stockholders Equity |
38.08B | 37.28B | 34.98B | 31.19B | 29.41B | 26.01B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.98B | 3.40B | 5.21B | 2.00B | 2.20B | Operating Cash Flow |
0.00 | 5.31B | 4.99B | 6.83B | 6.84B | 5.04B | Investing Cash Flow |
0.00 | 6.33B | -788.01M | -2.03B | -4.44B | -3.01B | Financing Cash Flow |
0.00 | -2.87B | -3.46B | -3.58B | -664.82M | 427.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥13.91B | 19.66 | 3.03% | 11.76% | 9.97% | ||
74 Outperform | ¥2.34T | 20.28 | 8.55% | 1.77% | 3.91% | 7.86% | |
72 Outperform | ¥3.43B | 13.11 | 3.80% | 13.49% | 17.08% | ||
69 Neutral | ¥34.51B | 10.65 | 2.54% | 5.01% | -39.78% | ||
66 Neutral | ¥9.51B | 60.27 | ― | 13.52% | -45.02% | ||
66 Neutral | ¥511.18B | 18.11 | 2.57% | 5.85% | 3.31% | ||
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% |